Skip to main content
Log in

Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam

  • Regular Articles
  • Published:
Tropical Animal Health and Production Aims and scope Submit manuscript


Reports of livestock infections with extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-E) are increasing. Based on interviews conducted over a 6-month period, we found that veterinarians in the Vietnamese province of Thai Binh prefer to prescribe colistin-based drugs (CBD) in chicken farms. We aimed to clarify whether CBD use selects for strains of colistin-resistant ESBL-E. With the cooperation of seven local households, we detected ESBL-E in chickens’ feces after treating chickens with CBD. Phylogenetic groupings and the presence of CTX-M/AmpC genes were determined, and the multi-antibiotic susceptibility of isolates was analyzed. Our results showed that ESBL-E presented in seven chickens’ feces from two households. Seventy-two percent of ESBL-E isolates harbored CTX-M9 and the phylogenetic group A; the colistin minimum inhibitory concentration (MIC) of all isolated ESBL-E ranged from 0.064 to 1 μg mL−1. Moreover, ESBL-E isolates were used to experimentally select for colistin resistance, and the effect of commercial CBD on ESBL-E was investigated. The results showed that an ESBL-E strain with a colistin MIC of 4 μg mL−1 was able to grow in media with CBD. Although CBD treatment was effective, in vitro experiments demonstrated that ESBL-E can easily acquire colistin resistance. Therefore, restrictions on colistin use are necessary to prevent the emergence of colistin-resistant bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  • Bargiacchi, O., Rossati, A., Car, P., Brustia, D., Brondolo, R., Rosa, F., Garavelli, P.L. and De Rosa, F.G., 2014. Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant gram-negative bacteria: case reports and review, Infection, doi: 10.1007/s15010-014-0618-0

    PubMed  Google Scholar 

  • Clermont, O., Bonacorsi, S. and Bingen, E., 2000. Rapid and simple determination of the Escherichia coli phylogenetic group, Appl Environ Microbiol, doi: 10.1128/AEM.66.10.4555-2000

    PubMed  PubMed Central  Google Scholar 

  • Froelich, J.M., Tran, K. and Wall, D., 2006. A pmrA constitutive mutant sensitizes Escherichia coli to deoxycholic acid, J Bacteriol, doi: 10.1128/JB.188.3.1180-1183.2006

    PubMed  PubMed Central  Google Scholar 

  • Huttner, B., Haustein, T., Uçkay, I., Renzi, G., Stewardson, A., Schaerrer, D., Agostinho, A., Andremont, A., Schrenzel, J., Pittet, D. and Harbarth, S., 2013. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial, J Antimicrob Chemother, doi: 10.1093/jac/dkt174

    Google Scholar 

  • Koike, M. and Iida, K., 1971. Effect of polymyxin on the bacteriophage receptors of the cell walls of gram-negative bacteria, J Bacteriol, 108, 1402–1411.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Krajewski, J., Bode-Boger, S.M., Troger, U., Martens-Lobenhoffer, J., Mulrooney, T., Mittelstadt, H., Russlies, M., Kirchner, R. and Knobloch, J.K., 2014. Successful treatment of extensively drug-resistant Pseudomonas aeruginosa osteomyelitis using a colistin- and tobramycin-impregnated PMMA spacer. Int J Antimicrob Agents, doi: 10.1016/j.ijantimicag.2014.05.023

    PubMed  Google Scholar 

  • Ku, Y.H., Lee, M.F., Chuang, Y.C., Chen C.C. and Yu, W.L., 2015. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum beta-lactamases, J Microbiol Immunol Infect, doi: 10.1016/j.jmii.2013.11.005

    Google Scholar 

  • Liu, Y.Y., Wang, Y., Walsh, T.R., 2015.Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect Dis, doi: 10.1016/S1473-3099(15)00424-7

    PubMed Central  Google Scholar 

  • Martis, N., Leroy. S. and Blanc, V., 2014. Colistin in multi-drug resistant Pseudomonas aeruginosa blood-stream infections: a narrative review for the clinician, J Infect, doi: 10.1016/j.jinf.2014.03.001

  • Nakamura, T., Komatsu, M., Yamasaki, K., Fukuda, S., Higuchi, T., Ono, T., Nishio, H., Sueyoshi, N., Kida, K., Satoh, K., Toda, H., Toyokawa, M., Nishi, I., Sakamoto, M., Akagi, M., Mizutani, T., Nakai, I., Kofuku, T., Orita, T., Zikimoto, T., Natsume S. and Wada, Y., 2014. Susceptibility of various oral antibacterial agents against extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae, J Infect Chemother, doi: 10.1016/j.jiac.2013.08.004

    Google Scholar 

  • Nakayama, T., Ueda, S., Huong, B.T., Tuyen, L.D., Komalamisra, C., Kusolsuk, T., Hirai T. and Yamamoto, Y., 2015. Wide dissemination of extended-spectrum beta-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula, Infect Drug Resist, doi: 10.2147/IDR.S74934

    PubMed  PubMed Central  Google Scholar 

  • Nhung NT, Cuong NV, Campbell J, Hoa NT, Bryant JE, Truc VN, Kiet BT, Jombart T, Trung NV, Hien VB, Thwaites G, Baker S. and Carrique-Mas J, 2015. High levels of antimicrobial resistance among eschechia coli isolates from livestock farms and synanthropic rats and shrews in the Mekong Delta of Vietnam, Appl Environ Microbiol, doi: 10.1128/AEM.03366-14

    PubMed  PubMed Central  Google Scholar 

  • Phong, L.Q., Ueda, S., Hue, T.N., Khanh, T.D., Van, T.H., Nga, T.T., Hirai, I., Nakayama, T., Kawahara, R., Hung, T.D., Mai Q.V. and Yamamoto, Y., 2015. Characterization of extended-spectrum beta-lactamase-producing Escherichia coli in retail meats and shrimp at a local market in Vietnam, Foodborne Pathog Dis, doi: 10.1089/fpd.2015.1954

    Google Scholar 

  • Quesada, A., Porrero, M.C., Tellez, S., Palmo, G., Garcia, M., Dominguez, L., 2015. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine, J Antimicrob Chemother, doi: 10.1093/jac/dku320

    Google Scholar 

  • Sasaki, T., Hirai, I., Niki, M., Nakamura, T., Komalamisra, C., Maipanich, W., Kusolsuk, T., Sa-Nguankiat, S., Pubampen S. and Yamamoto, Y., 2010. High prevalence of CTX-M beta-lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand, J Antimicrob Chemother, doi: 10.1093/jac/dkq008

    PubMed  Google Scholar 

  • Shah, A.A., Hasan, F., Ahmed, S. and Hameed, A., 2004. Characteristics, epidemiology and clinical importance of emerging strains of gram-negative bacilli producing extended-spectrum beta-lactamases, Res Microbiol, doi: 10.1016/j.resmic.2004.02.009

    PubMed  Google Scholar 

  • Suzuki, S., Ohnishi, M., Kawanishi, M., Akiba, M. and Kuroda, M., 2016. Investigation of a plasmid genome database for colistin-resistance gene mcr-1, Lancet Infect Dis, doi: 10.1016/S1473-3099(16)00008-6

    PubMed  Google Scholar 

  • Yamaguchi, T., Okihashi, M., Harada, K., Konishi, K., Do, M.H., Bui, H.D., Nguyen, T.D., Nguyen, P.D., Chau, V.V., Dao, K.T., Nguyen, H.T., Kajimura, K., Kumeda, Y., Bui, C.T., Vien, M.Q., Le, N.H., Hirata, K. and Yamamoto, Y., 2015. Antibiotic residue monitoring results for pork, chiken and beef samples in Vietnam in 2012–2013, J Agric Food Chem, doi: 10.1021/jf505254y

    Google Scholar 

Download references


This work was supported by the Japan Agency for Medical Research and Development (AMED) and the Japan International Cooperation Agency (JICA) as part of the Science and Technology Research Partnership for Sustainable Development (SATREPS).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Yoshinori Sumimura.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nakayama, T., Jinnai, M., Kawahara, R. et al. Frequent use of colistin-based drug treatment to eliminate extended-spectrum beta-lactamase-producing Escherichia coli in backyard chicken farms in Thai Binh Province, Vietnam. Trop Anim Health Prod 49, 31–37 (2017).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: